

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | polyketide metabolic process (GO:0030638) | 6.35128292 |
| 2 | doxorubicin metabolic process (GO:0044598) | 6.35128292 |
| 3 | daunorubicin metabolic process (GO:0044597) | 6.35128292 |
| 4 | sulfur amino acid catabolic process (GO:0000098) | 5.73706994 |
| 5 | angiotensin maturation (GO:0002003) | 5.67302382 |
| 6 | coenzyme catabolic process (GO:0009109) | 5.63370208 |
| 7 | cellular modified amino acid catabolic process (GO:0042219) | 5.39558484 |
| 8 | NADH metabolic process (GO:0006734) | 5.24244225 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 5.18675218 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.18675218 |
| 11 | L-phenylalanine catabolic process (GO:0006559) | 5.14573665 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.14573665 |
| 13 | Golgi transport vesicle coating (GO:0048200) | 5.02231311 |
| 14 | COPI coating of Golgi vesicle (GO:0048205) | 5.02231311 |
| 15 | epoxygenase P450 pathway (GO:0019373) | 4.89377473 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.76523392 |
| 17 | cysteine metabolic process (GO:0006534) | 4.65131925 |
| 18 | hormone catabolic process (GO:0042447) | 4.63549701 |
| 19 | aromatic amino acid family catabolic process (GO:0009074) | 4.58913724 |
| 20 | glycosphingolipid catabolic process (GO:0046479) | 4.50998832 |
| 21 | lysine metabolic process (GO:0006553) | 4.43109316 |
| 22 | lysine catabolic process (GO:0006554) | 4.43109316 |
| 23 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.38549417 |
| 24 | serine family amino acid catabolic process (GO:0009071) | 4.36805443 |
| 25 | alpha-linolenic acid metabolic process (GO:0036109) | 4.34387702 |
| 26 | heme transport (GO:0015886) | 4.26646348 |
| 27 | biotin metabolic process (GO:0006768) | 4.23243285 |
| 28 | cofactor catabolic process (GO:0051187) | 4.21965114 |
| 29 | kynurenine metabolic process (GO:0070189) | 4.15876179 |
| 30 | glyoxylate metabolic process (GO:0046487) | 4.15018155 |
| 31 | glycolipid catabolic process (GO:0019377) | 4.13990967 |
| 32 | tryptophan catabolic process (GO:0006569) | 4.06633737 |
| 33 | indole-containing compound catabolic process (GO:0042436) | 4.06633737 |
| 34 | indolalkylamine catabolic process (GO:0046218) | 4.06633737 |
| 35 | urea cycle (GO:0000050) | 4.06263398 |
| 36 | urea metabolic process (GO:0019627) | 4.06263398 |
| 37 | drug metabolic process (GO:0017144) | 4.01516148 |
| 38 | bile acid biosynthetic process (GO:0006699) | 4.00524929 |
| 39 | glycine metabolic process (GO:0006544) | 3.99729444 |
| 40 | valine metabolic process (GO:0006573) | 3.93224905 |
| 41 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.90726013 |
| 42 | protein retention in ER lumen (GO:0006621) | 3.90068925 |
| 43 | fructose metabolic process (GO:0006000) | 3.89292085 |
| 44 | tryptophan metabolic process (GO:0006568) | 3.81531488 |
| 45 | cellular amino acid catabolic process (GO:0009063) | 3.78636272 |
| 46 | homocysteine metabolic process (GO:0050667) | 3.78427741 |
| 47 | high-density lipoprotein particle remodeling (GO:0034375) | 3.78013695 |
| 48 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.76696392 |
| 49 | serine family amino acid metabolic process (GO:0009069) | 3.71232507 |
| 50 | alpha-amino acid catabolic process (GO:1901606) | 3.69837787 |
| 51 | proline biosynthetic process (GO:0006561) | 3.69544268 |
| 52 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.69058723 |
| 53 | negative regulation of fibrinolysis (GO:0051918) | 3.66165046 |
| 54 | nitrogen cycle metabolic process (GO:0071941) | 3.66005918 |
| 55 | amino-acid betaine metabolic process (GO:0006577) | 3.63010283 |
| 56 | response to dietary excess (GO:0002021) | 3.60331839 |
| 57 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.59162563 |
| 58 | regulation of triglyceride catabolic process (GO:0010896) | 3.56943961 |
| 59 | primary alcohol catabolic process (GO:0034310) | 3.55068361 |
| 60 | somite rostral/caudal axis specification (GO:0032525) | 3.50901721 |
| 61 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.49136746 |
| 62 | protein carboxylation (GO:0018214) | 3.49136746 |
| 63 | negative regulation of sterol transport (GO:0032372) | 3.48222184 |
| 64 | negative regulation of cholesterol transport (GO:0032375) | 3.48222184 |
| 65 | regulation of protein activation cascade (GO:2000257) | 3.47236857 |
| 66 | bile acid metabolic process (GO:0008206) | 3.45407986 |
| 67 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 3.44211187 |
| 68 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.43667309 |
| 69 | maintenance of protein location in nucleus (GO:0051457) | 3.42914974 |
| 70 | complement activation, alternative pathway (GO:0006957) | 3.42401396 |
| 71 | flavonoid metabolic process (GO:0009812) | 3.40852842 |
| 72 | aromatic amino acid family metabolic process (GO:0009072) | 3.40529533 |
| 73 | ceramide catabolic process (GO:0046514) | 3.39622903 |
| 74 | acylglycerol homeostasis (GO:0055090) | 3.38647917 |
| 75 | triglyceride homeostasis (GO:0070328) | 3.38647917 |
| 76 | serine family amino acid biosynthetic process (GO:0009070) | 3.38495558 |
| 77 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 3.37727678 |
| 78 | cofactor transport (GO:0051181) | 3.36223191 |
| 79 | quinone metabolic process (GO:1901661) | 3.36136979 |
| 80 | plasma lipoprotein particle clearance (GO:0034381) | 3.35246891 |
| 81 | L-ascorbic acid metabolic process (GO:0019852) | 3.34858566 |
| 82 | regulation of cholesterol esterification (GO:0010872) | 3.34427363 |
| 83 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.33518393 |
| 84 | response to thyroid hormone (GO:0097066) | 3.33482555 |
| 85 | oligosaccharide catabolic process (GO:0009313) | 3.33274431 |
| 86 | negative regulation of telomerase activity (GO:0051974) | 3.32220233 |
| 87 | low-density lipoprotein particle clearance (GO:0034383) | 3.30713252 |
| 88 | reverse cholesterol transport (GO:0043691) | 3.27585914 |
| 89 | regulation of fibrinolysis (GO:0051917) | 3.27395701 |
| 90 | plasma lipoprotein particle assembly (GO:0034377) | 3.27328967 |
| 91 | glutamate metabolic process (GO:0006536) | 3.26074106 |
| 92 | plasma lipoprotein particle remodeling (GO:0034369) | 3.25994926 |
| 93 | protein-lipid complex remodeling (GO:0034368) | 3.25994926 |
| 94 | macromolecular complex remodeling (GO:0034367) | 3.25994926 |
| 95 | drug catabolic process (GO:0042737) | 3.25961106 |
| 96 | branched-chain amino acid catabolic process (GO:0009083) | 3.25827889 |
| 97 | regulation of complement activation (GO:0030449) | 3.25523354 |
| 98 | aspartate family amino acid catabolic process (GO:0009068) | 3.25364435 |
| 99 | acetyl-CoA metabolic process (GO:0006084) | 3.24017030 |
| 100 | amino acid import (GO:0043090) | 3.23935109 |
| 101 | barbed-end actin filament capping (GO:0051016) | 3.23320850 |
| 102 | carboxylic acid catabolic process (GO:0046395) | 3.19307309 |
| 103 | organic acid catabolic process (GO:0016054) | 3.19307309 |
| 104 | phospholipid efflux (GO:0033700) | 3.15797426 |
| 105 | protein-lipid complex assembly (GO:0065005) | 3.15381368 |
| 106 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.14915845 |
| 107 | regulation of cholesterol homeostasis (GO:2000188) | 3.14364300 |
| 108 | proline metabolic process (GO:0006560) | 3.14105164 |
| 109 | ethanol oxidation (GO:0006069) | 3.12853368 |
| 110 | gluconeogenesis (GO:0006094) | 3.12635882 |
| 111 | xenobiotic catabolic process (GO:0042178) | 3.12280247 |
| 112 | 2-oxoglutarate metabolic process (GO:0006103) | 3.11718487 |
| 113 | sodium ion export (GO:0071436) | 3.09474065 |
| 114 | protein localization to kinetochore (GO:0034501) | 3.09359610 |
| 115 | regulation of cholesterol storage (GO:0010885) | 3.08061369 |
| 116 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.07878372 |
| 117 | positive regulation of extracellular matrix organization (GO:1903055) | 3.07550634 |
| 118 | rRNA transcription (GO:0009303) | 3.07051987 |
| 119 | intestinal cholesterol absorption (GO:0030299) | 3.05151385 |
| 120 | short-chain fatty acid metabolic process (GO:0046459) | 3.04286630 |
| 121 | branched-chain amino acid metabolic process (GO:0009081) | 3.03446374 |
| 122 | cellular ketone body metabolic process (GO:0046950) | 3.01716205 |
| 123 | phenylpropanoid metabolic process (GO:0009698) | 3.00955876 |
| 124 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 3.00032271 |
| 125 | folic acid metabolic process (GO:0046655) | 2.99482553 |
| 126 | hexose biosynthetic process (GO:0019319) | 2.96529596 |
| 127 | imidazole-containing compound metabolic process (GO:0052803) | 2.96238071 |
| 128 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.95550715 |
| 129 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.95550715 |
| 130 | apoptotic cell clearance (GO:0043277) | 2.94887730 |
| 131 | monosaccharide biosynthetic process (GO:0046364) | 2.93501884 |
| 132 | peroxisome fission (GO:0016559) | 2.92497960 |
| 133 | regulation of cholesterol metabolic process (GO:0090181) | 2.91967196 |
| 134 | protein localization to endosome (GO:0036010) | 2.88852004 |
| 135 | sphingolipid catabolic process (GO:0030149) | 2.88258572 |
| 136 | membrane lipid catabolic process (GO:0046466) | 2.87707317 |
| 137 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.85289212 |
| 138 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.84487131 |
| 139 | cellular copper ion homeostasis (GO:0006878) | 2.82895868 |
| 140 | adhesion of symbiont to host cell (GO:0044650) | 2.81846358 |
| 141 | virion attachment to host cell (GO:0019062) | 2.81846358 |
| 142 | GDP-mannose metabolic process (GO:0019673) | 2.81215137 |
| 143 | glucose 6-phosphate metabolic process (GO:0051156) | 2.79304719 |
| 144 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.77490600 |
| 145 | surfactant homeostasis (GO:0043129) | 2.75958335 |
| 146 | cholesterol efflux (GO:0033344) | 2.72932548 |
| 147 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.72793043 |
| 148 | positive regulation of leukocyte degranulation (GO:0043302) | 2.72769685 |
| 149 | adhesion of symbiont to host (GO:0044406) | 2.72183787 |
| 150 | serine transport (GO:0032329) | 2.72001813 |
| 151 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.70142712 |
| 152 | cell volume homeostasis (GO:0006884) | 2.68845214 |
| 153 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.67768006 |
| 154 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.66389655 |
| 155 | positive regulation of cholesterol efflux (GO:0010875) | 2.65644387 |
| 156 | peptide catabolic process (GO:0043171) | 2.64048925 |
| 157 | transcytosis (GO:0045056) | 2.61637561 |
| 158 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.60146693 |
| 159 | regulation of inclusion body assembly (GO:0090083) | 2.58477805 |
| 160 | lipoprotein transport (GO:0042953) | 2.58303640 |
| 161 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.55659671 |
| 162 | negative regulation of inclusion body assembly (GO:0090084) | 2.54556298 |
| 163 | oxaloacetate metabolic process (GO:0006107) | 2.52681004 |
| 164 | glycolytic process (GO:0006096) | 2.52010379 |
| 165 | amyloid precursor protein catabolic process (GO:0042987) | 2.48087514 |
| 166 | L-serine transport (GO:0015825) | 2.47207382 |
| 167 | peptidyl-proline hydroxylation (GO:0019511) | 2.45608637 |
| 168 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.45242733 |
| 169 | tricarboxylic acid metabolic process (GO:0072350) | 2.43749137 |
| 170 | 4-hydroxyproline metabolic process (GO:0019471) | 2.43526261 |
| 171 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.42578904 |
| 172 | vesicle coating (GO:0006901) | 2.42336497 |
| 173 | neutral amino acid transport (GO:0015804) | 2.42060664 |
| 174 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.41828389 |
| 175 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.41156888 |
| 176 | amino sugar catabolic process (GO:0046348) | 2.40196113 |
| 177 | L-amino acid import (GO:0043092) | 2.38247511 |
| 178 | endothelial cell chemotaxis (GO:0035767) | 2.36835712 |
| 179 | carnitine metabolic process (GO:0009437) | 2.35662866 |
| 180 | positive regulation of nuclease activity (GO:0032075) | 2.35342568 |
| 181 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.35329089 |
| 182 | transferrin transport (GO:0033572) | 2.34238768 |
| 183 | iron coordination entity transport (GO:1901678) | 2.32267358 |
| 184 | glycosylceramide metabolic process (GO:0006677) | 2.31608859 |
| 185 | vitamin transmembrane transport (GO:0035461) | 2.29133878 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.17783674 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.46619629 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.26329773 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.06470526 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.95222365 |
| 6 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.85519072 |
| 7 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.85519072 |
| 8 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.85519072 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.76484749 |
| 10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.29188084 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.01167490 |
| 12 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.95227484 |
| 13 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.66313199 |
| 14 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.61755771 |
| 15 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.54254263 |
| 16 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.43490764 |
| 17 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.35944798 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.34146279 |
| 19 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.31441554 |
| 20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.16164799 |
| 21 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.12568164 |
| 22 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.06904877 |
| 23 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.03363390 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.01503595 |
| 25 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.01214120 |
| 26 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.97388414 |
| 27 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.94628568 |
| 28 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.91436602 |
| 29 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.90975045 |
| 30 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.83776785 |
| 31 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.81209945 |
| 32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.79885632 |
| 33 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.78145041 |
| 34 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.77795668 |
| 35 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.69806310 |
| 36 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.68838172 |
| 37 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.67833223 |
| 38 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.67242350 |
| 39 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.65160912 |
| 40 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.60387074 |
| 41 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.57971267 |
| 42 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.57021088 |
| 43 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.56392049 |
| 44 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.55230235 |
| 45 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.53894101 |
| 46 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.52365807 |
| 47 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.46618918 |
| 48 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.43077531 |
| 49 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.42131683 |
| 50 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.40782925 |
| 51 | GATA1_22025678_ChIP-Seq_K562_Human | 1.40384064 |
| 52 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.40370777 |
| 53 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.39145920 |
| 54 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.38203139 |
| 55 | KDM2B_26808549_Chip-Seq_K562_Human | 1.35189351 |
| 56 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.33610444 |
| 57 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31470063 |
| 58 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.30709116 |
| 59 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.29915778 |
| 60 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.29886201 |
| 61 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.28258809 |
| 62 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.27224462 |
| 63 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.26339524 |
| 64 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.24718129 |
| 65 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.24271555 |
| 66 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.23421794 |
| 67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.22230007 |
| 68 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.20647952 |
| 69 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.20553183 |
| 70 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.20369382 |
| 71 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.20271516 |
| 72 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.19888461 |
| 73 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.19840940 |
| 74 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.19541885 |
| 75 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19363002 |
| 76 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.19021015 |
| 77 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.18791255 |
| 78 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.18366568 |
| 79 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.17050418 |
| 80 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.16932718 |
| 81 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.16448978 |
| 82 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.16391179 |
| 83 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.15945937 |
| 84 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.15481695 |
| 85 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.15318053 |
| 86 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.15134413 |
| 87 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.14724928 |
| 88 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14384928 |
| 89 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13588786 |
| 90 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.12911293 |
| 91 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.12670856 |
| 92 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12411244 |
| 93 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.12123521 |
| 94 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.11326011 |
| 95 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.10844720 |
| 96 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.10636520 |
| 97 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.10313772 |
| 98 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.09840041 |
| 99 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.09826164 |
| 100 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.09085910 |
| 101 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.08085417 |
| 102 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.07278966 |
| 103 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.07033910 |
| 104 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06202148 |
| 105 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.05594089 |
| 106 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.05444288 |
| 107 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.05419869 |
| 108 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.05039526 |
| 109 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.04888436 |
| 110 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.04620016 |
| 111 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04482830 |
| 112 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03392013 |
| 113 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.03156221 |
| 114 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.02881649 |
| 115 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02852628 |
| 116 | GATA1_19941826_ChIP-Seq_K562_Human | 1.02762966 |
| 117 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00517513 |
| 118 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.99922159 |
| 119 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.99892470 |
| 120 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.99457808 |
| 121 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99330053 |
| 122 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.99189021 |
| 123 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.99041821 |
| 124 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98869948 |
| 125 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.98849368 |
| 126 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.98628490 |
| 127 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.95307793 |
| 128 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.94579225 |
| 129 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.93154526 |
| 130 | P68_20966046_ChIP-Seq_HELA_Human | 0.91750912 |
| 131 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.91613371 |
| 132 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90500764 |
| 133 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.90237765 |
| 134 | MYC_22102868_ChIP-Seq_BL_Human | 0.90084556 |
| 135 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.89426907 |
| 136 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.88801515 |
| 137 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.88509190 |
| 138 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.88479184 |
| 139 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.87989811 |
| 140 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.87828107 |
| 141 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.87795602 |
| 142 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.87637455 |
| 143 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.87383279 |
| 144 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.87373216 |
| 145 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.84536358 |
| 146 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.84276642 |
| 147 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.83601929 |
| 148 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.83220443 |
| 149 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.83119092 |
| 150 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.82296942 |
| 151 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.81276402 |
| 152 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.81202450 |
| 153 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.81053064 |
| 154 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.80948086 |
| 155 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.80847964 |
| 156 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.80183122 |
| 157 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 0.80150151 |
| 158 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.79672256 |
| 159 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.79605277 |
| 160 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.79018106 |
| 161 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.78862008 |
| 162 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.76698217 |
| 163 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.75871959 |
| 164 | ATF3_27146783_Chip-Seq_COLON_Human | 0.75534450 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.06416496 |
| 2 | MP0005360_urolithiasis | 5.83828498 |
| 3 | MP0005058_abnormal_lysosome_morphology | 4.76377197 |
| 4 | MP0005365_abnormal_bile_salt | 4.52638247 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 4.42604391 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.11155816 |
| 7 | MP0003011_delayed_dark_adaptation | 4.05052356 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.74213312 |
| 9 | MP0002254_reproductive_system_inflammat | 3.37477900 |
| 10 | MP0004264_abnormal_extraembryonic_tissu | 3.10666254 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.95594621 |
| 12 | MP0009840_abnormal_foam_cell | 2.86505029 |
| 13 | MP0003252_abnormal_bile_duct | 2.69086101 |
| 14 | MP0008260_abnormal_autophagy | 2.68521076 |
| 15 | MP0003705_abnormal_hypodermis_morpholog | 2.66207148 |
| 16 | MP0005451_abnormal_body_composition | 2.35380431 |
| 17 | MP0006035_abnormal_mitochondrial_morpho | 2.31739668 |
| 18 | MP0003690_abnormal_glial_cell | 2.31500288 |
| 19 | MP0005332_abnormal_amino_acid | 2.30818047 |
| 20 | MP0001666_abnormal_nutrient_absorption | 2.20908644 |
| 21 | MP0000609_abnormal_liver_physiology | 2.07461954 |
| 22 | MP0005319_abnormal_enzyme/_coenzyme | 2.01060386 |
| 23 | MP0002332_abnormal_exercise_endurance | 1.97678240 |
| 24 | MP0004858_abnormal_nervous_system | 1.93426894 |
| 25 | MP0005083_abnormal_biliary_tract | 1.93197828 |
| 26 | MP0000343_altered_response_to | 1.90141261 |
| 27 | MP0003890_abnormal_embryonic-extraembry | 1.86182958 |
| 28 | MP0005075_abnormal_melanosome_morpholog | 1.85101750 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.83568106 |
| 30 | MP0004019_abnormal_vitamin_homeostasis | 1.75500852 |
| 31 | MP0004043_abnormal_pH_regulation | 1.74687279 |
| 32 | MP0003656_abnormal_erythrocyte_physiolo | 1.73503434 |
| 33 | MP0003186_abnormal_redox_activity | 1.72077701 |
| 34 | MP0002118_abnormal_lipid_homeostasis | 1.69915570 |
| 35 | MP0005499_abnormal_olfactory_system | 1.68911307 |
| 36 | MP0005394_taste/olfaction_phenotype | 1.68911307 |
| 37 | MP0003172_abnormal_lysosome_physiology | 1.68882253 |
| 38 | MP0003453_abnormal_keratinocyte_physiol | 1.67889770 |
| 39 | MP0005409_darkened_coat_color | 1.67038419 |
| 40 | MP0006036_abnormal_mitochondrial_physio | 1.66890392 |
| 41 | MP0002877_abnormal_melanocyte_morpholog | 1.62541255 |
| 42 | MP0010234_abnormal_vibrissa_follicle | 1.62305968 |
| 43 | MP0005266_abnormal_metabolism | 1.59075881 |
| 44 | MP0006292_abnormal_olfactory_placode | 1.57685282 |
| 45 | MP0003303_peritoneal_inflammation | 1.51493200 |
| 46 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.46920582 |
| 47 | MP0003879_abnormal_hair_cell | 1.44829717 |
| 48 | MP0003195_calcinosis | 1.44793986 |
| 49 | MP0000920_abnormal_myelination | 1.42984926 |
| 50 | MP0004957_abnormal_blastocyst_morpholog | 1.42919933 |
| 51 | MP0003183_abnormal_peptide_metabolism | 1.42364040 |
| 52 | MP0002735_abnormal_chemical_nociception | 1.40233404 |
| 53 | MP0005670_abnormal_white_adipose | 1.39790868 |
| 54 | MP0006082_CNS_inflammation | 1.35766084 |
| 55 | MP0003279_aneurysm | 1.32580983 |
| 56 | MP0005166_decreased_susceptibility_to | 1.32473722 |
| 57 | MP0009278_abnormal_bone_marrow | 1.31684356 |
| 58 | MP0002970_abnormal_white_adipose | 1.23102737 |
| 59 | MP0001853_heart_inflammation | 1.21733180 |
| 60 | MP0003634_abnormal_glial_cell | 1.21448003 |
| 61 | MP0001764_abnormal_homeostasis | 1.19859616 |
| 62 | MP0003566_abnormal_cell_adhesion | 1.18382511 |
| 63 | MP0000598_abnormal_liver_morphology | 1.18206707 |
| 64 | MP0009643_abnormal_urine_homeostasis | 1.17928488 |
| 65 | MP0005171_absent_coat_pigmentation | 1.17718315 |
| 66 | MP0008961_abnormal_basal_metabolism | 1.17336921 |
| 67 | MP0005501_abnormal_skin_physiology | 1.17258303 |
| 68 | MP0004859_abnormal_synaptic_plasticity | 1.12732005 |
| 69 | MP0005397_hematopoietic_system_phenotyp | 1.12180404 |
| 70 | MP0001545_abnormal_hematopoietic_system | 1.12180404 |
| 71 | MP0005376_homeostasis/metabolism_phenot | 1.10863854 |
| 72 | MP0005076_abnormal_cell_differentiation | 1.10017990 |
| 73 | MP0000747_muscle_weakness | 1.09298823 |
| 74 | MP0002148_abnormal_hypersensitivity_rea | 1.08640440 |
| 75 | MP0010352_gastrointestinal_tract_polyps | 1.07170738 |
| 76 | MP0008874_decreased_physiological_sensi | 1.05471193 |
| 77 | MP0008872_abnormal_physiological_respon | 0.98411713 |
| 78 | MP0005375_adipose_tissue_phenotype | 0.98241136 |
| 79 | MP0000858_altered_metastatic_potential | 0.96764837 |
| 80 | MP0002090_abnormal_vision | 0.93423657 |
| 81 | MP0003091_abnormal_cell_migration | 0.90891805 |
| 82 | MP0005380_embryogenesis_phenotype | 0.89845655 |
| 83 | MP0001672_abnormal_embryogenesis/_devel | 0.89845655 |
| 84 | MP0002088_abnormal_embryonic_growth/wei | 0.87462829 |
| 85 | MP0005636_abnormal_mineral_homeostasis | 0.86169475 |
| 86 | MP0003984_embryonic_growth_retardation | 0.85755585 |
| 87 | MP0002653_abnormal_ependyma_morphology | 0.85553094 |
| 88 | MP0004947_skin_inflammation | 0.84496963 |
| 89 | MP0002971_abnormal_brown_adipose | 0.83959751 |
| 90 | MP0000003_abnormal_adipose_tissue | 0.83515379 |
| 91 | MP0009115_abnormal_fat_cell | 0.83495115 |
| 92 | MP0004185_abnormal_adipocyte_glucose | 0.82990338 |
| 93 | MP0002078_abnormal_glucose_homeostasis | 0.81196926 |
| 94 | MP0004270_analgesia | 0.80504995 |
| 95 | MP0001881_abnormal_mammary_gland | 0.80422824 |
| 96 | MP0003868_abnormal_feces_composition | 0.78422955 |
| 97 | MP0004233_abnormal_muscle_weight | 0.77561648 |
| 98 | MP0001958_emphysema | 0.77151518 |
| 99 | MP0009765_abnormal_xenobiotic_induced | 0.76449147 |
| 100 | MP0004147_increased_porphyrin_level | 0.75526998 |
| 101 | MP0001502_abnormal_circadian_rhythm | 0.75163643 |
| 102 | MP0002098_abnormal_vibrissa_morphology | 0.74901152 |
| 103 | MP0005535_abnormal_body_temperature | 0.74513079 |
| 104 | MP0003638_abnormal_response/metabolism_ | 0.74170136 |
| 105 | MP0000249_abnormal_blood_vessel | 0.74050084 |
| 106 | MP0005023_abnormal_wound_healing | 0.73677723 |
| 107 | MP0003122_maternal_imprinting | 0.73546230 |
| 108 | MP0005621_abnormal_cell_physiology | 0.72098208 |
| 109 | MP0000358_abnormal_cell_content/ | 0.71149562 |
| 110 | MP0002269_muscular_atrophy | 0.70875060 |
| 111 | MP0008057_abnormal_DNA_replication | 0.70270830 |
| 112 | MP0005448_abnormal_energy_balance | 0.69810665 |
| 113 | MP0003300_gastrointestinal_ulcer | 0.69703115 |
| 114 | MP0000604_amyloidosis | 0.69481437 |
| 115 | MP0003448_altered_tumor_morphology | 0.69017780 |
| 116 | MP0009763_increased_sensitivity_to | 0.68588258 |
| 117 | MP0001727_abnormal_embryo_implantation | 0.68095115 |
| 118 | MP0005423_abnormal_somatic_nervous | 0.68093271 |
| 119 | MP0009764_decreased_sensitivity_to | 0.67427530 |
| 120 | MP0002419_abnormal_innate_immunity | 0.67263720 |
| 121 | MP0003283_abnormal_digestive_organ | 0.66400909 |
| 122 | MP0000678_abnormal_parathyroid_gland | 0.65387124 |
| 123 | MP0005666_abnormal_adipose_tissue | 0.65033903 |
| 124 | MP0003436_decreased_susceptibility_to | 0.64884292 |
| 125 | MP0001849_ear_inflammation | 0.64322759 |
| 126 | MP0002086_abnormal_extraembryonic_tissu | 0.64017390 |
| 127 | MP0005165_increased_susceptibility_to | 0.63789712 |
| 128 | MP0002998_abnormal_bone_remodeling | 0.62894644 |
| 129 | MP0001756_abnormal_urination | 0.61879328 |
| 130 | MP0004782_abnormal_surfactant_physiolog | 0.61758531 |
| 131 | MP0008469_abnormal_protein_level | 0.61465279 |
| 132 | MP0005257_abnormal_intraocular_pressure | 0.60776668 |
| 133 | MP0002127_abnormal_cardiovascular_syste | 0.59939809 |
| 134 | MP0009642_abnormal_blood_homeostasis | 0.58859109 |
| 135 | MP0005452_abnormal_adipose_tissue | 0.57190107 |
| 136 | MP0008873_increased_physiological_sensi | 0.55520983 |
| 137 | MP0002876_abnormal_thyroid_physiology | 0.54459294 |
| 138 | MP0003123_paternal_imprinting | 0.54041149 |
| 139 | MP0002132_abnormal_respiratory_system | 0.53863788 |
| 140 | MP0001730_embryonic_growth_arrest | 0.52800586 |
| 141 | MP0002822_catalepsy | 0.51954766 |
| 142 | MP0005334_abnormal_fat_pad | 0.51947909 |
| 143 | MP0005647_abnormal_sex_gland | 0.51105407 |
| 144 | MP0002092_abnormal_eye_morphology | 0.50945967 |
| 145 | MP0002796_impaired_skin_barrier | 0.50145422 |
| 146 | MP0003329_amyloid_beta_deposits | 0.49750566 |
| 147 | MP0002138_abnormal_hepatobiliary_system | 0.49654369 |
| 148 | MP0000350_abnormal_cell_proliferation | 0.49433161 |
| 149 | MP0003718_maternal_effect | 0.47382113 |
| 150 | MP0003075_altered_response_to | 0.47288092 |
| 151 | MP0005248_abnormal_Harderian_gland | 0.44724476 |
| 152 | MP0008770_decreased_survivor_rate | 0.44019982 |
| 153 | MP0005167_abnormal_blood-brain_barrier | 0.41505640 |
| 154 | MP0009672_abnormal_birth_weight | 0.41387764 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypochromic microcytic anemia (HP:0004840) | 5.89456869 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.85754778 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.85754778 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 4.85754778 |
| 5 | Abnormality of the lower motor neuron (HP:0002366) | 4.63069655 |
| 6 | Multiple enchondromatosis (HP:0005701) | 4.61809895 |
| 7 | Intrahepatic cholestasis (HP:0001406) | 4.60207048 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.53679244 |
| 9 | Hyperglycinuria (HP:0003108) | 4.52160499 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 4.32805923 |
| 11 | Bilateral microphthalmos (HP:0007633) | 4.26257707 |
| 12 | Xanthomatosis (HP:0000991) | 4.26245324 |
| 13 | Hypobetalipoproteinemia (HP:0003563) | 4.05287368 |
| 14 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.02657106 |
| 15 | Deep venous thrombosis (HP:0002625) | 3.91206659 |
| 16 | Abnormality of the intrinsic pathway (HP:0010989) | 3.88479118 |
| 17 | Abnormality of glycine metabolism (HP:0010895) | 3.88321937 |
| 18 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.88321937 |
| 19 | Neurofibrillary tangles (HP:0002185) | 3.79852308 |
| 20 | Hepatoblastoma (HP:0002884) | 3.79693029 |
| 21 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.76154100 |
| 22 | Hyperammonemia (HP:0001987) | 3.75866065 |
| 23 | Increased cerebral lipofuscin (HP:0011813) | 3.74034967 |
| 24 | Mutism (HP:0002300) | 3.57539195 |
| 25 | Abnormal cartilage morphology (HP:0002763) | 3.56756497 |
| 26 | Vacuolated lymphocytes (HP:0001922) | 3.49895862 |
| 27 | Ragged-red muscle fibers (HP:0003200) | 3.48812288 |
| 28 | Tetraplegia (HP:0002445) | 3.33165687 |
| 29 | Gout (HP:0001997) | 3.32805050 |
| 30 | Hyperglycinemia (HP:0002154) | 3.32639125 |
| 31 | Axonal loss (HP:0003447) | 3.27411653 |
| 32 | Hypolipoproteinemia (HP:0010981) | 3.26310872 |
| 33 | Skin nodule (HP:0200036) | 3.25917869 |
| 34 | Loss of speech (HP:0002371) | 3.24293975 |
| 35 | Ketosis (HP:0001946) | 3.22487193 |
| 36 | Dysostosis multiplex (HP:0000943) | 3.17355970 |
| 37 | Hyperlipoproteinemia (HP:0010980) | 3.17290150 |
| 38 | Prolonged partial thromboplastin time (HP:0003645) | 3.14101013 |
| 39 | Neuronal loss in central nervous system (HP:0002529) | 3.13352470 |
| 40 | Malnutrition (HP:0004395) | 3.08979532 |
| 41 | Cerebral inclusion bodies (HP:0100314) | 3.07839430 |
| 42 | Hypoalphalipoproteinemia (HP:0003233) | 2.99265173 |
| 43 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.98748309 |
| 44 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.93873538 |
| 45 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.91905952 |
| 46 | Hypoglycemic coma (HP:0001325) | 2.90922540 |
| 47 | Ketoacidosis (HP:0001993) | 2.85347810 |
| 48 | Hemorrhage of the eye (HP:0011885) | 2.83686003 |
| 49 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.81195390 |
| 50 | Distal upper limb amyotrophy (HP:0007149) | 2.77466598 |
| 51 | Upper limb amyotrophy (HP:0009129) | 2.77466598 |
| 52 | Complement deficiency (HP:0004431) | 2.74380980 |
| 53 | Ependymoma (HP:0002888) | 2.72231477 |
| 54 | Nuclear cataract (HP:0100018) | 2.71155844 |
| 55 | Supranuclear gaze palsy (HP:0000605) | 2.69101306 |
| 56 | Upper motor neuron abnormality (HP:0002127) | 2.68221490 |
| 57 | Increased serum pyruvate (HP:0003542) | 2.67429789 |
| 58 | Abnormality of glycolysis (HP:0004366) | 2.67429789 |
| 59 | Epidermoid cyst (HP:0200040) | 2.67229217 |
| 60 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.66728635 |
| 61 | Hyperbilirubinemia (HP:0002904) | 2.64294097 |
| 62 | Diminished motivation (HP:0000745) | 2.62699641 |
| 63 | Hypercholesterolemia (HP:0003124) | 2.58678168 |
| 64 | Apathy (HP:0000741) | 2.57162706 |
| 65 | Metabolic acidosis (HP:0001942) | 2.57112389 |
| 66 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.56213250 |
| 67 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.56213250 |
| 68 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.56213250 |
| 69 | Tetraparesis (HP:0002273) | 2.54467099 |
| 70 | Vertebral compression fractures (HP:0002953) | 2.53611105 |
| 71 | Abnormality of methionine metabolism (HP:0010901) | 2.50866905 |
| 72 | Steatorrhea (HP:0002570) | 2.49274322 |
| 73 | Reduced antithrombin III activity (HP:0001976) | 2.46460653 |
| 74 | J-shaped sella turcica (HP:0002680) | 2.45940640 |
| 75 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.44934447 |
| 76 | Status epilepticus (HP:0002133) | 2.44926389 |
| 77 | Glomerulonephritis (HP:0000099) | 2.44335991 |
| 78 | Reticulocytosis (HP:0001923) | 2.43792738 |
| 79 | Mucopolysacchariduria (HP:0008155) | 2.43141533 |
| 80 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.43141533 |
| 81 | Neoplasm of striated muscle (HP:0009728) | 2.43067227 |
| 82 | Fat malabsorption (HP:0002630) | 2.40699023 |
| 83 | Rhabdomyosarcoma (HP:0002859) | 2.39915774 |
| 84 | Irritability (HP:0000737) | 2.39731230 |
| 85 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.38481191 |
| 86 | Abnormality of the periventricular white matter (HP:0002518) | 2.38440467 |
| 87 | Spastic tetraparesis (HP:0001285) | 2.38065032 |
| 88 | Abnormality of purine metabolism (HP:0004352) | 2.36593268 |
| 89 | Male infertility (HP:0003251) | 2.35600207 |
| 90 | Abnormality of nucleobase metabolism (HP:0010932) | 2.35036367 |
| 91 | Cholelithiasis (HP:0001081) | 2.35028935 |
| 92 | Spastic diplegia (HP:0001264) | 2.34253943 |
| 93 | Dicarboxylic aciduria (HP:0003215) | 2.33973743 |
| 94 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.33973743 |
| 95 | Joint hemorrhage (HP:0005261) | 2.33508102 |
| 96 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.32840339 |
| 97 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.31922567 |
| 98 | Prolonged neonatal jaundice (HP:0006579) | 2.30932267 |
| 99 | Testicular atrophy (HP:0000029) | 2.30040187 |
| 100 | Interstitial pulmonary disease (HP:0006530) | 2.29066443 |
| 101 | Abnormal gallbladder morphology (HP:0012437) | 2.27620435 |
| 102 | Myocardial infarction (HP:0001658) | 2.27450005 |
| 103 | Hypochromic anemia (HP:0001931) | 2.26769949 |
| 104 | Rib fusion (HP:0000902) | 2.25653796 |
| 105 | Hyperventilation (HP:0002883) | 2.21641160 |
| 106 | Abnormality of the common coagulation pathway (HP:0010990) | 2.20491524 |
| 107 | Growth hormone excess (HP:0000845) | 2.19192972 |
| 108 | Lethargy (HP:0001254) | 2.17334284 |
| 109 | Acanthocytosis (HP:0001927) | 2.17189638 |
| 110 | Abnormality of the Achilles tendon (HP:0005109) | 2.16590015 |
| 111 | Ankle clonus (HP:0011448) | 2.14849653 |
| 112 | Horizontal nystagmus (HP:0000666) | 2.14364486 |
| 113 | Impaired proprioception (HP:0010831) | 2.12609179 |
| 114 | Thin bony cortex (HP:0002753) | 2.12170773 |
| 115 | Abnormality of complement system (HP:0005339) | 2.11521212 |
| 116 | Abnormality of serum amino acid levels (HP:0003112) | 2.11485163 |
| 117 | Limb hypertonia (HP:0002509) | 2.11445641 |
| 118 | Nonimmune hydrops fetalis (HP:0001790) | 2.09881868 |
| 119 | Vaginal fistula (HP:0004320) | 2.09756333 |
| 120 | Dementia (HP:0000726) | 2.09626521 |
| 121 | Hydroxyprolinuria (HP:0003080) | 2.08806767 |
| 122 | Abnormality of proline metabolism (HP:0010907) | 2.08806767 |
| 123 | Peripheral hypomyelination (HP:0007182) | 2.08596418 |
| 124 | Hyperparathyroidism (HP:0000843) | 2.08173374 |
| 125 | Vomiting (HP:0002013) | 2.06667062 |
| 126 | Amyotrophic lateral sclerosis (HP:0007354) | 2.06643591 |
| 127 | Progressive muscle weakness (HP:0003323) | 2.05742490 |
| 128 | Hypoplasia of the fovea (HP:0007750) | 2.05233289 |
| 129 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.05233289 |
| 130 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.03892348 |
| 131 | Abnormality of the gallbladder (HP:0005264) | 2.03808326 |
| 132 | Delayed CNS myelination (HP:0002188) | 2.03377206 |
| 133 | Pseudobulbar signs (HP:0002200) | 2.02533242 |
| 134 | Polycythemia (HP:0001901) | 2.01950384 |
| 135 | Nausea (HP:0002018) | 2.01892769 |
| 136 | Cholecystitis (HP:0001082) | 2.01440413 |
| 137 | Abnormal gallbladder physiology (HP:0012438) | 2.01440413 |
| 138 | Confusion (HP:0001289) | 1.99024956 |
| 139 | Hyperuricemia (HP:0002149) | 1.98852811 |
| 140 | Increased purine levels (HP:0004368) | 1.98852811 |
| 141 | Abnormality of iron homeostasis (HP:0011031) | 1.98766772 |
| 142 | Hypokinesia (HP:0002375) | 1.98423298 |
| 143 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.97589386 |
| 144 | Increased serum ferritin (HP:0003281) | 1.96983155 |
| 145 | Global brain atrophy (HP:0002283) | 1.96783518 |
| 146 | Poikilocytosis (HP:0004447) | 1.96124680 |
| 147 | Abnormality of the salivary glands (HP:0010286) | 1.96011842 |
| 148 | Hepatocellular carcinoma (HP:0001402) | 1.95873067 |
| 149 | Hand muscle atrophy (HP:0009130) | 1.95141527 |
| 150 | Bile duct proliferation (HP:0001408) | 1.91570282 |
| 151 | Abnormal biliary tract physiology (HP:0012439) | 1.91570282 |
| 152 | Insomnia (HP:0100785) | 1.91078197 |
| 153 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.89991170 |
| 154 | Conjugated hyperbilirubinemia (HP:0002908) | 1.89490520 |
| 155 | Bone pain (HP:0002653) | 1.87690368 |
| 156 | Abnormal trabecular bone morphology (HP:0100671) | 1.87479744 |
| 157 | Annular pancreas (HP:0001734) | 1.86921839 |
| 158 | Elevated alkaline phosphatase (HP:0003155) | 1.86564370 |
| 159 | Multiple lipomas (HP:0001012) | 1.85855152 |
| 160 | Fused cervical vertebrae (HP:0002949) | 1.83587911 |
| 161 | Abnormal neuron morphology (HP:0012757) | 1.81982230 |
| 162 | Abnormality of the motor neurons (HP:0002450) | 1.81982230 |
| 163 | Rough bone trabeculation (HP:0100670) | 1.81855278 |
| 164 | Delusions (HP:0000746) | 1.81555558 |
| 165 | Subcapsular cataract (HP:0000523) | 1.81385574 |
| 166 | Achilles tendon contracture (HP:0001771) | 1.80835633 |
| 167 | Athetosis (HP:0002305) | 1.79177859 |
| 168 | Disinhibition (HP:0000734) | 1.78884344 |
| 169 | Urinary incontinence (HP:0000020) | 1.78617535 |
| 170 | Personality changes (HP:0000751) | 1.78278570 |
| 171 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.75547056 |
| 172 | Hammertoe (HP:0001765) | 1.73615697 |
| 173 | Rapidly progressive (HP:0003678) | 1.73012706 |
| 174 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.72835193 |
| 175 | Distal sensory impairment (HP:0002936) | 1.72703464 |
| 176 | Hypertensive crisis (HP:0100735) | 1.70931133 |
| 177 | Abnormality of the costochondral junction (HP:0000919) | 1.67585652 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 6.62007881 |
| 2 | ERN1 | 6.04109680 |
| 3 | GRK5 | 4.65369096 |
| 4 | GRK6 | 4.10976586 |
| 5 | PRPF4B | 3.26238007 |
| 6 | BCKDK | 3.05626696 |
| 7 | GRK1 | 3.03775296 |
| 8 | TRIM28 | 2.90438368 |
| 9 | TESK1 | 2.79763910 |
| 10 | PIM2 | 2.78003693 |
| 11 | TSSK6 | 2.49516732 |
| 12 | TTK | 2.41331960 |
| 13 | MAPK15 | 2.39926121 |
| 14 | IRAK3 | 2.39830139 |
| 15 | CSF1R | 2.33372173 |
| 16 | ADRBK2 | 2.19910256 |
| 17 | TIE1 | 2.15438068 |
| 18 | MAPK7 | 2.15384959 |
| 19 | MAP2K4 | 2.05024529 |
| 20 | TGFBR2 | 2.04914759 |
| 21 | TYRO3 | 2.03032283 |
| 22 | NME2 | 1.87787975 |
| 23 | STK10 | 1.77755664 |
| 24 | MOS | 1.75416444 |
| 25 | MATK | 1.73187301 |
| 26 | EPHA2 | 1.70538318 |
| 27 | MAP3K3 | 1.64689589 |
| 28 | TBK1 | 1.62506593 |
| 29 | MAP3K13 | 1.58783323 |
| 30 | SIK1 | 1.56554391 |
| 31 | WNK1 | 1.49305781 |
| 32 | LMTK2 | 1.46938158 |
| 33 | GRK7 | 1.45316426 |
| 34 | NTRK1 | 1.36335826 |
| 35 | AKT3 | 1.36284740 |
| 36 | MAP3K10 | 1.35275934 |
| 37 | PRKG2 | 1.33204522 |
| 38 | TRIB3 | 1.27269617 |
| 39 | DDR2 | 1.26859999 |
| 40 | EPHA4 | 1.25351894 |
| 41 | CDK6 | 1.24699718 |
| 42 | ICK | 1.20050329 |
| 43 | RIPK1 | 1.18502934 |
| 44 | NEK1 | 1.16357890 |
| 45 | CAMK4 | 1.15491938 |
| 46 | LIMK1 | 1.14101984 |
| 47 | MAP3K1 | 1.02036724 |
| 48 | NEK6 | 1.00184421 |
| 49 | PDPK1 | 0.99341918 |
| 50 | MAPKAPK3 | 0.98408073 |
| 51 | PAK4 | 0.93589309 |
| 52 | FGFR3 | 0.92968369 |
| 53 | PAK6 | 0.92639946 |
| 54 | CDK7 | 0.92278122 |
| 55 | MST1R | 0.92058555 |
| 56 | MAP3K9 | 0.90160181 |
| 57 | PLK1 | 0.89935469 |
| 58 | MAP2K6 | 0.87821365 |
| 59 | SIK3 | 0.87744891 |
| 60 | FER | 0.86998048 |
| 61 | PDGFRA | 0.86015697 |
| 62 | PDK3 | 0.82858198 |
| 63 | PDK4 | 0.82858198 |
| 64 | MAPK12 | 0.82001371 |
| 65 | EPHB1 | 0.81920804 |
| 66 | CAMK2G | 0.81866099 |
| 67 | CHEK2 | 0.79117453 |
| 68 | MAP3K2 | 0.78680285 |
| 69 | MAP3K7 | 0.77886693 |
| 70 | FGFR4 | 0.76487963 |
| 71 | ERBB4 | 0.75000666 |
| 72 | EPHA3 | 0.72671459 |
| 73 | NEK2 | 0.70318262 |
| 74 | AKT2 | 0.70179767 |
| 75 | BUB1 | 0.70168838 |
| 76 | CDK4 | 0.70168763 |
| 77 | ADRBK1 | 0.70053568 |
| 78 | CSK | 0.68827835 |
| 79 | BRAF | 0.66932552 |
| 80 | LATS2 | 0.65795318 |
| 81 | HIPK2 | 0.65064624 |
| 82 | ALK | 0.64111956 |
| 83 | MARK2 | 0.61144553 |
| 84 | DAPK3 | 0.59345973 |
| 85 | KDR | 0.57890773 |
| 86 | ABL2 | 0.56909710 |
| 87 | FLT3 | 0.55391719 |
| 88 | DAPK1 | 0.55181443 |
| 89 | PINK1 | 0.54829316 |
| 90 | CDK11A | 0.54541616 |
| 91 | NEK9 | 0.53618476 |
| 92 | PKN2 | 0.53267179 |
| 93 | MTOR | 0.52927237 |
| 94 | RAF1 | 0.52189403 |
| 95 | PRKD2 | 0.51912735 |
| 96 | PDK2 | 0.51862894 |
| 97 | CDK14 | 0.51826785 |
| 98 | PTK2 | 0.51815882 |
| 99 | MAP3K5 | 0.50554090 |
| 100 | JAK2 | 0.50428403 |
| 101 | CDK15 | 0.49807993 |
| 102 | PRKAA1 | 0.49734372 |
| 103 | PRKACG | 0.49146859 |
| 104 | PIM1 | 0.48715331 |
| 105 | CAMKK1 | 0.47775793 |
| 106 | MAPK11 | 0.47405094 |
| 107 | CCNB1 | 0.47092968 |
| 108 | CDK18 | 0.46744856 |
| 109 | DAPK2 | 0.46716834 |
| 110 | AURKA | 0.44380909 |
| 111 | CHEK1 | 0.44294528 |
| 112 | ERBB2 | 0.44161462 |
| 113 | PRKCG | 0.44148765 |
| 114 | EIF2AK1 | 0.44110659 |
| 115 | EEF2K | 0.43303292 |
| 116 | CAMK2B | 0.43240137 |
| 117 | PRKCI | 0.43035010 |
| 118 | MET | 0.42259217 |
| 119 | CDK9 | 0.40532910 |
| 120 | IRAK2 | 0.39681720 |
| 121 | STK38 | 0.39652098 |
| 122 | MAPK10 | 0.38514147 |
| 123 | KSR2 | 0.38330067 |
| 124 | SCYL2 | 0.38301673 |
| 125 | CDC42BPA | 0.37748355 |
| 126 | TYK2 | 0.37542451 |
| 127 | RPS6KA2 | 0.37103974 |
| 128 | PRKD1 | 0.37044704 |
| 129 | CAMK1D | 0.36492791 |
| 130 | EPHB2 | 0.35790687 |
| 131 | IGF1R | 0.35769163 |
| 132 | PDK1 | 0.34913450 |
| 133 | ARAF | 0.32814008 |
| 134 | TAOK1 | 0.32595429 |
| 135 | GSK3A | 0.30946246 |
| 136 | MAPK4 | 0.30901916 |
| 137 | CSNK1E | 0.30661738 |
| 138 | STK16 | 0.30554548 |
| 139 | ACVR1B | 0.28913039 |
| 140 | CDK2 | 0.28143863 |
| 141 | MAP3K8 | 0.27426642 |
| 142 | BMX | 0.27405725 |
| 143 | PRKAA2 | 0.27230878 |
| 144 | PRKCD | 0.25690279 |
| 145 | PBK | 0.25388112 |
| 146 | EIF2AK2 | 0.24468574 |
| 147 | TAOK3 | 0.23947619 |
| 148 | WEE1 | 0.21743168 |
| 149 | ITK | 0.20153794 |
| 150 | RPS6KA3 | 0.18931894 |
| 151 | MAP3K11 | 0.18585466 |
| 152 | INSRR | 0.18575561 |
| 153 | PAK1 | 0.18574733 |
| 154 | DYRK1B | 0.18250369 |
| 155 | TESK2 | 0.17946797 |
| 156 | TAOK2 | 0.17390225 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.80522335 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.50478627 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.44275998 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.04769853 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.86188013 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.70913244 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.64327293 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.64218145 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62564589 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.55382125 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.52141520 |
| 12 | Lysosome_Homo sapiens_hsa04142 | 2.48920768 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.28438788 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.26015531 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.24288664 |
| 16 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.16122434 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.99905530 |
| 18 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.99545164 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.96993034 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.95968908 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.91811328 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.90119530 |
| 23 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.85511152 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.81353583 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.77166299 |
| 26 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.76704041 |
| 27 | Carbon metabolism_Homo sapiens_hsa01200 | 1.71314616 |
| 28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.69532860 |
| 29 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.66536645 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.64007311 |
| 31 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.63735396 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.61359017 |
| 33 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.59722811 |
| 34 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.58507545 |
| 35 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.53678491 |
| 36 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.52440434 |
| 37 | Sulfur relay system_Homo sapiens_hsa04122 | 1.51033569 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.50694144 |
| 39 | Galactose metabolism_Homo sapiens_hsa00052 | 1.49501361 |
| 40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.47343404 |
| 41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.45273021 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.44881268 |
| 43 | Bile secretion_Homo sapiens_hsa04976 | 1.41153573 |
| 44 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.37303904 |
| 45 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.32036662 |
| 46 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.30560574 |
| 47 | Histidine metabolism_Homo sapiens_hsa00340 | 1.27366417 |
| 48 | Retinol metabolism_Homo sapiens_hsa00830 | 1.26358995 |
| 49 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.20233057 |
| 50 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.18828955 |
| 51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.17684767 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.15912724 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.14361611 |
| 54 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.08793290 |
| 55 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.07181331 |
| 56 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.06805277 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 1.05608556 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.04022166 |
| 59 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.02810410 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00836967 |
| 61 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.99389061 |
| 62 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.98164222 |
| 63 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.98137071 |
| 64 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.91478183 |
| 65 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87573947 |
| 66 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.85695665 |
| 67 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.83817142 |
| 68 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.82249780 |
| 69 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.80284003 |
| 70 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.80230914 |
| 71 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.78849512 |
| 72 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.77821420 |
| 73 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.77463233 |
| 74 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.75612694 |
| 75 | Hepatitis C_Homo sapiens_hsa05160 | 0.74557652 |
| 76 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.71402935 |
| 77 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.70110390 |
| 78 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.66493854 |
| 79 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.65964882 |
| 80 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.65729541 |
| 81 | Bladder cancer_Homo sapiens_hsa05219 | 0.62338409 |
| 82 | Lysine degradation_Homo sapiens_hsa00310 | 0.62010773 |
| 83 | Pertussis_Homo sapiens_hsa05133 | 0.59265954 |
| 84 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58390852 |
| 85 | Metabolic pathways_Homo sapiens_hsa01100 | 0.58032073 |
| 86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57057021 |
| 87 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55180133 |
| 88 | Phagosome_Homo sapiens_hsa04145 | 0.54424946 |
| 89 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.54402871 |
| 90 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.50192860 |
| 91 | Endocytosis_Homo sapiens_hsa04144 | 0.44719840 |
| 92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44163812 |
| 93 | Salmonella infection_Homo sapiens_hsa05132 | 0.42730136 |
| 94 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.42615793 |
| 95 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.40323242 |
| 96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39898769 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39389871 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35213563 |
| 99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.33818453 |
| 100 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.33048283 |
| 101 | Apoptosis_Homo sapiens_hsa04210 | 0.32447408 |
| 102 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.30681456 |
| 103 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.29590798 |
| 104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.28437329 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.27891439 |
| 106 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.26509518 |
| 107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.26062672 |
| 108 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.25335274 |
| 109 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.24742178 |
| 110 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.24208072 |
| 111 | Legionellosis_Homo sapiens_hsa05134 | 0.21469445 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.20977573 |
| 113 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.19513126 |
| 114 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.17552901 |
| 115 | Thyroid cancer_Homo sapiens_hsa05216 | 0.14634251 |
| 116 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.13919715 |
| 117 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.11181395 |
| 118 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.11142309 |
| 119 | Prion diseases_Homo sapiens_hsa05020 | 0.10629613 |
| 120 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.08691687 |
| 121 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.07599105 |
| 122 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.01120738 |
| 123 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0715949 |
| 124 | Mineral absorption_Homo sapiens_hsa04978 | -0.0568914 |
| 125 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0559880 |
| 126 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0525529 |
| 127 | RNA transport_Homo sapiens_hsa03013 | -0.0519435 |
| 128 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0284420 |
| 129 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | -0.0021182 |

